These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 30678614)
1. Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer's Disease. Gulcan HO; Mavideniz A; Sahin MF; Orhan IE Curr Med Chem; 2019; 26(18):3260-3278. PubMed ID: 30678614 [TBL] [Abstract][Full Text] [Related]
2. Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design. Van Manh N; Hoang VH; Ngo VTH; Ann J; Jang TH; Ha JH; Song JY; Ha HJ; Kim H; Kim YH; Lee J; Lee J Eur J Med Chem; 2021 Dec; 226():113819. PubMed ID: 34536669 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease. Fang Y; Zhou H; Gu Q; Xu J Eur J Med Chem; 2019 Apr; 167():133-145. PubMed ID: 30771601 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold. Ramsbeck D; Buchholz M; Koch B; Böhme L; Hoffmann T; Demuth HU; Heiser U J Med Chem; 2013 Sep; 56(17):6613-25. PubMed ID: 23886302 [TBL] [Abstract][Full Text] [Related]
5. Exploring the binding mode of PQ912 against secretory glutaminyl cyclase through systematic exploitation of conformational ensembles. Chandran R; Dileep KV Chem Biol Drug Des; 2021 Nov; 98(5):850-856. PubMed ID: 34423556 [TBL] [Abstract][Full Text] [Related]
6. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities. Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465 [TBL] [Abstract][Full Text] [Related]
7. Fluoro-benzimidazole derivatives to cure Alzheimer's disease: In-silico studies, synthesis, structure-activity relationship and in vivo evaluation for β secretase enzyme inhibition. Ali S; Asad MHHB; Maity S; Zada W; Rizvanov AA; Iqbal J; Babak B; Hussain I Bioorg Chem; 2019 Jul; 88():102936. PubMed ID: 31054426 [No Abstract] [Full Text] [Related]
8. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds. Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161 [TBL] [Abstract][Full Text] [Related]
9. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease. Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806 [TBL] [Abstract][Full Text] [Related]
10. Benzimidazole and Benzoxazole Derivatives Against Alzheimer's Disease. Faydalı N; Arpacı ÖT Chem Biodivers; 2024 Jun; 21(6):e202400123. PubMed ID: 38494443 [TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic agents against Alzheimer's disease from natural sources. Park SY Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936 [TBL] [Abstract][Full Text] [Related]
12. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease. Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase. Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488 [TBL] [Abstract][Full Text] [Related]
14. Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease. Prati F; Cavalli A; Bolognesi ML Molecules; 2016 Apr; 21(4):466. PubMed ID: 27070562 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
16. Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles. Ozadali-Sari K; Tüylü Küçükkılınç T; Ayazgok B; Balkan A; Unsal-Tan O Bioorg Chem; 2017 Jun; 72():208-214. PubMed ID: 28478328 [TBL] [Abstract][Full Text] [Related]
17. Disease-modifying therapies in Alzheimer's disease: how far have we come? Hüll M; Berger M; Heneka M Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors. Gabr MT; Abdel-Raziq MS Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutaminyl cyclase ameliorates amyloid pathology in an animal model of Alzheimer's disease via the modulation of γ-secretase activity. Song H; Chang YJ; Moon M; Park SK; Tran PT; Hoang VH; Lee J; Mook-Jung I J Alzheimers Dis; 2015; 43(3):797-807. PubMed ID: 25114069 [TBL] [Abstract][Full Text] [Related]
20. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Anand P; Singh B; Singh N Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]